Company Filing History:
4 out of 5 
1 out of 81 
1 out of 1 Years Active: 2013-2021
Title: Haiching Ma: Innovator in Histone Deacetylase Inhibitors and Selective Kinase Inhibitors
Introduction
Haiching Ma is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of histone deacetylase inhibitors and selective kinase inhibitors. With a total of 5 patents to his name, Ma's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Haiching Ma's latest patents is focused on histone deacetylase inhibitors and methods of use thereof. This invention relates to methods of modulating the activity of histone deacetylases (HDACs) and includes methods for treating HDAC-associated diseases such as cancers, inflammatory disorders, and neurodegenerative disorders. The patent also provides novel compounds and compositions, along with methods for their preparation. Another significant patent involves selective kinase inhibitors, which details methods for modulating the activity of JAK3. This includes the use of specific compounds to treat JAK3-associated diseases, particularly inflammatory and autoimmune disorders.
Career Highlights
Throughout his career, Haiching Ma has worked with reputable organizations such as Reaction Biology Corporation and Fox Chase Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Haiching Ma's notable coworkers include Yuren Wang and Jeffrey R. Peterson. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
Haiching Ma's contributions to the field of biochemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of various diseases.